CURAGENE Co., Ltd.

CURAGENE Co., Ltd., leading the future with technology and trust

About Us Overview

About Us

Overview

Company	CURAGENE Co., Ltd.
CEO	DONG HUN KIM
Specialization	Manufacturing of medical supplies and other pharmaceutical/non-pharmaceutical/medical device related industries
Main product	3D stereoscopic medical dressing foam and composite medical products
Establishment date	08ust 12, 2019
Headquarters/Research Center	607, Manufacturing Building, Techtree Yeongtong Knowledge Industry Center, 55 Sinwon-ro, Yeongtong-gu, Suwon-si, Gyeonggi-do
Homepage	www.curagene.co.kr

History

2019

08 CURAGENE Corporation, Factory Establishment
08 Suwon City Startup Audition Excellence Award
08 Signing of M.O.U. with Ajou University Graduate School of Pharmaceutical Clinical Studies
08 Ajou University Family Business Registration
08 Signing of Industry-Academic Cooperation Agreement with Ajou University

2020

2021

06 Obtained GMP and Valifoam product approval from the Ministry of Food and Drug Safety
06 Kaiser Holdings Co., Ltd. equity investment agreement
11 “Valleyform” Newly Registered as a Middle-Class Treatment Material by the Health Insurance Review & Assessment Service

2022

01 Alico Pharmaceutical Co., Ltd. signs domestic 1st type distribution contract (1st)
03 Suwon Techtree Youngtong Knowledge Industry Center New Factory Construction and Relocation

2023

02 Signed an equity investment agreement with Enpoyu University Joint Technology Holding Company
03 Establishment of a research department (KOITA)
03 Selection of Ajou University Hospital Open Laboratory Project
05 Alico Pharmaceutical Co., Ltd. signs domestic distribution contract for 2 additional specifications of Valleyform (2nd)
05 Selection of Small and Medium Business Innovation Voucher Projects
12 Selection of general government projects for purchase conditional development of commercialization technology for small and medium-sized ventures
12 Suwon Mayor's Award of Merit

2024

03 Selection of Ajou University Hospital Open Laboratory Project
04 “Valleyform Additional Specification 2 Types” Obtained Ministry of Food and Drug Safety Approval
05 Obtained R&D certification for small and medium-sized venture companies
12 “Valleyform Additional Specification 2 Types” Newly Registered in the Middle Classification of Treatment Materials by the Health Insurance Review & Assessment Service

2025

02 Alico Pharmaceutical Co., Ltd. signs domestic distribution contract for 2 additional specifications of Valleyform (3rd)
02 Wound healing composition containing succinic acid and method for producing same PCT application
02 Vietnam “Valleyform” trademark application
02 Ajou University Medical Center Bio Core Facility Construction Project Selected as Government Project
03 Obtained the Excellent Company Award for Job Invention Reward
04 Acquired Performance Sharing Enterprise Certification
05 Government project selection for female scientists and engineers R&D career return project
05 Selection of government project for export business development of domestic companies
05 Export Challenge Enterprise IP Risk Response Capacity Enhancement Project Selection